CBDX (Curative Biosciences) EBITDA Margin %: 0.00% (As of Mar. 2018)


What is Curative Biosciences EBITDA Margin %?

Curative Biosciences CBDX EBITDA Margin % is 0.00% as of Mar. 2018.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Curative Biosciences's EBITDA for the three months ended in Mar. 2018 was $-0.03 Mil. Curative Biosciences's Revenue for the three months ended in Mar. 2018 was $0.00 Mil. Therefore, Curative Biosciences's EBITDA margin for the quarter that ended in Mar. 2018 was 0.00%.

Curative Biosciences  (OTCPK:CBDX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Curative Biosciences EBITDA Margin % Related Terms

Curative Biosciences EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Curative Biosciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences EBITDA Margin % Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -476.54 0.00 0.00 0.00 0.00

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBDX vs ACUR, CVLB, RDGL: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biosciences EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's EBITDA Margin % falls into.


Curative Biosciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Curative Biosciences's EBITDA Margin % for the fiscal year that ended in Jun. 2017 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2017 )/Revenue (A: Jun. 2017 )
=-0.05/0
= %

Curative Biosciences's EBITDA Margin % for the quarter that ended in Mar. 2018 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2018 )/Revenue (Q: Mar. 2018 )
=-0.032/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Curative Biosciences (CBDX) has a EBITDA Margin % of 0.00% as of Mar. 2018. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Curative Biosciences and its competitors.
Is Curative Biosciences' EBITDA Margin % too high?
Curative Biosciences' current EBITDA Margin % is 0.00%.
How does Curative Biosciences' EBITDA Margin % compare to ACUR and CVLB?
Curative Biosciences' EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.54, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Curative Biosciences and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curative Biosciences's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biosciences stock overvalued right now?
Curative Biosciences (CBDX) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Curative Biosciences (CBDX), the current EBITDA Margin % is 0.00% as of Mar. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biosciences Business Description

Address 2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.